ANI Pharmaceuticals Inc
NASDAQ:ANIP

Watchlist Manager
ANI Pharmaceuticals Inc Logo
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Watchlist
Price: 57.86 USD -1.33% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
ANI Pharmaceuticals Inc?
Write Note

Relative Value

The Relative Value of one ANIP stock under the Base Case scenario is 125.31 USD. Compared to the current market price of 57.86 USD, ANI Pharmaceuticals Inc is Undervalued by 54%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ANIP Relative Value
Base Case
125.31 USD
Undervaluation 54%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
45
Median 3Y
2.4
Median 5Y
2.3
Industry
2.5
Forward
2
vs History
3
vs Industry
10
Median 3Y
-8.5
Median 5Y
-14.2
Industry
21.9
Forward
12
vs History
50
vs Industry
34
Median 3Y
12.1
Median 5Y
12.9
Industry
16.5
vs History
88
vs Industry
22
Median 3Y
18.4
Median 5Y
19.2
Industry
23.6
vs History
25
vs Industry
29
Median 3Y
2.4
Median 5Y
2.3
Industry
2.1
vs History
92
vs Industry
41
Median 3Y
3
Median 5Y
2.8
Industry
2.6
Forward
2.8
vs History
90
vs Industry
48
Median 3Y
4.9
Median 5Y
4.7
Industry
5.2
vs History
23
vs Industry
30
Median 3Y
15.4
Median 5Y
13.2
Industry
13.3
Forward
11
vs History
17
vs Industry
17
Median 3Y
23.1
Median 5Y
24.8
Industry
16.6
Forward
11
vs History
46
vs Industry
33
Median 3Y
12.5
Median 5Y
16.9
Industry
15.6
vs History
39
vs Industry
26
Median 3Y
13.8
Median 5Y
18.7
Industry
19.1
vs History
41
vs Industry
35
Median 3Y
1.6
Median 5Y
1.4
Industry
1.9

Multiples Across Competitors

ANIP Competitors Multiples
ANI Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
ANI Pharmaceuticals Inc
NASDAQ:ANIP
1.2B USD 1.8 161.9 20.6 79.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
749.7B USD 18.3 89.6 48.1 53.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.2 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
372B USD 4.2 25.3 12.2 15.9
US
Merck & Co Inc
NYSE:MRK
257.3B USD 4.1 21.2 10.7 12.8
CH
Roche Holding AG
SIX:ROG
201.7B CHF 3.4 17.5 9.9 11.7
UK
AstraZeneca PLC
LSE:AZN
163B GBP 4.2 31.8 169.5 254
CH
Novartis AG
SIX:NOVN
179.6B CHF 4.1 11.5 9.9 13.9
US
Pfizer Inc
NYSE:PFE
146B USD 2.4 34.3 10.3 15.6

See Also

Discover More
Back to Top